Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
12/29/1999 | WO1999067388A1 Antisense oligonucleotide inhibiting the expression of il-10 protein |
12/29/1999 | WO1999067384A2 Prostate cancer-associated genes |
12/29/1999 | WO1999067382A2 Angiopoietin-like growth factor sequences |
12/29/1999 | WO1999067380A1 c-Cbl SUPPRESSION OF NEOPLASTIC TRANSFORMATION |
12/29/1999 | WO1999067379A2 Structured antisense nucleic acid molecules |
12/29/1999 | WO1999067378A1 ANTISENSE OLIGONUCLEOTIDE CONSTRUCTS BASED ON β-ARABINOFURANOSE AND ITS ANALOGUES |
12/29/1999 | WO1999067377A1 Human arf-related proteins |
12/29/1999 | WO1999067369A1 Cell cycle regulatory factor |
12/29/1999 | WO1999067365A1 A method for in vitro maturation of human gametes |
12/29/1999 | WO1999067294A1 Antigenic complex comprising immunostimulatory peptide, cd4, and chemokine receptor domain for hiv treatment and immune disorders |
12/29/1999 | WO1999067293A1 Peptide composition as immunogen for the treatment of allergy |
12/29/1999 | WO1999067288A1 Tumor antigen peptides originating in cyclophilin b |
12/29/1999 | WO1999067286A2 Novel staphylococcus peptides for bacterial interference |
12/29/1999 | WO1999067284A2 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy |
12/29/1999 | WO1999067283A2 Two-kinase domain mitogen- and stress-activated protein kinases and uses thereof |
12/29/1999 | WO1999067281A1 Substituted cyclooctadepsipeptides |
12/29/1999 | WO1999067280A1 Novel method for preparing cyclosporin derivatives |
12/29/1999 | WO1999067279A1 Compounds of unstable dipeptidyl peptidase iv inhibitors |
12/29/1999 | WO1999067278A1 Prodrugs of dipeptidyl peptidase iv inhibitors |
12/29/1999 | WO1999067268A1 Diacylglycerol o-acyltransferase |
12/29/1999 | WO1999067230A1 INHIBITORS OF α4β1 MEDIATED CELL ADHESION |
12/29/1999 | WO1999066959A2 Compositions and methods for delivery of genetic material for altering neuronal growth, regeneration, and survival |
12/29/1999 | WO1999066957A2 Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens |
12/29/1999 | WO1999066952A1 Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic lhrh peptides |
12/29/1999 | WO1999066950A1 Synthetic somatostatin immunogen for growth promotion in farm animals |
12/29/1999 | WO1999066949A2 An antimicrobial effective against gram-positive pathogens |
12/29/1999 | WO1999066948A2 Use of a dipeptide for stimulating repair processes |
12/29/1999 | WO1999066947A1 Adjuvant therapy |
12/29/1999 | WO1999066946A1 Compositions and methods for inducing apoptosis in e6-expressing cells |
12/29/1999 | WO1999066945A1 Compositions and methods for inhibiting bone resorption |
12/29/1999 | WO1999066944A1 Methods for identifying novel multimeric agents that modulate receptors |
12/29/1999 | WO1999066941A1 Herbal extract composition and method with immune-boosting capability |
12/29/1999 | WO1999066934A1 CYCLIC AMINO ACID COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS |
12/29/1999 | WO1999066930A1 Compositions and methods for treating elevated blood cholesterol |
12/29/1999 | WO1999066926A1 Compositions comprising phenylaminothiophenacetic acid derivatives for the treatment of acute or adult respiratory distress syndrome (ards) and infant respiratory distress syndrome (irds) |
12/29/1999 | WO1999066923A1 Application for utility patent for improved enriched platelet wound healant |
12/29/1999 | WO1999066909A2 Method and compositions for the treatment or amelioration of female sexual dysfunction |
12/29/1999 | WO1999066906A1 Sticking plaster for controlled release of natural interferon |
12/29/1999 | WO1999066903A2 Large porous particles emitted from an inhaler |
12/29/1999 | WO1999066879A2 Systemic immune activation method using nucleic acid-lipid complexes |
12/29/1999 | WO1999066797A1 Enriched platelet wound healant |
12/29/1999 | WO1999060133A3 Human nucleic acid methylases |
12/29/1999 | WO1999059523A3 Topical pharmaceutical compositions useful for the treatment of cutaneous or circulatory pathologies on inflammatory, immune, proliferative or degenerative basis |
12/29/1999 | WO1999058647A3 Human deadenylating nuclease, its production and its use |
12/29/1999 | WO1999058640A3 Mct-1, a human oncogene |
12/29/1999 | WO1999058563A3 Moraxella catharralis proteins |
12/29/1999 | WO1999057320B1 Antisense modulation of cd40 expression |
12/29/1999 | WO1999057140A3 Growth-associated protease inhibitor heavy chain precursor |
12/29/1999 | WO1999055377A3 Polyol-ifn-beta conjugates |
12/29/1999 | WO1999054436A3 Nucleic acids and proteins of c. elegans insulin-like genes and uses thereof |
12/29/1999 | WO1999051779A3 Glaucoma therapeutics and diagnostics |
12/29/1999 | WO1999051626A3 Template associated npy y2-receptor agonists |
12/29/1999 | WO1999047156A3 Compositions for modulating cell differentiation comprising a lipid and a morphogen |
12/29/1999 | WO1999045950A3 Methods of suppressing microglial activation |
12/29/1999 | WO1998055150A8 Txu-7-pap immunotoxin and use thereof |
12/29/1999 | WO1997040147A8 Antigenically reactive regions of the hepatitis a virus polyprotein |
12/29/1999 | EP0967289A1 Improvements in gene therapy using compositions comprising a polynucleotide and a nuclease inhibitor |
12/29/1999 | EP0967288A1 Transfection system for the transfer of nucleic acids into cells |
12/29/1999 | EP0967284A1 Phosphodiesterases |
12/29/1999 | EP0967279A1 Helicobacter pylori cytotoxin useful for vaccines and diagnostics |
12/29/1999 | EP0967277A2 Production of chimeric mouse-human antibodies with specificity to human tumor antigens |
12/29/1999 | EP0967276A2 Anti-tumor agent comprising salmosin |
12/29/1999 | EP0967224A1 Novel protein, its gene, reagents for inducing apoptosis, and anticancer agents |
12/29/1999 | EP0967222A1 Cyclic depsipeptides and drugs containing the same as the active ingredient |
12/29/1999 | EP0966971A1 Cerebral stroke/cerebral edema preventive or remedy containing il-8 binding inhibitor as active ingredient |
12/29/1999 | EP0966537A2 AN $i(EX VIVO) ANIMAL OR CHALLENGE MODEL AS METHOD TO MEASURE PROTECTIVE IMMUNITY DIRECTED AGAINST PARASITES AND VACCINES SHOWN TO BE PROTECTIVE IN SAID METHOD |
12/29/1999 | EP0966536A1 Factor x analogues with a modified protease cleavage site |
12/29/1999 | EP0966535A1 Epitopes of the protein pre-m/m of the dengue virus, synthetic peptides |
12/29/1999 | EP0966534A1 Compositions and methods for elimination of unwanted cells |
12/29/1999 | EP0966533A1 Activity dependent neurotrophic factor iii (adnf iii) |
12/29/1999 | EP0966532A1 Biological material for treating a mammal by antibody gene transfer and pharmaceutical composition containing same |
12/29/1999 | EP0966530A2 Secreted proteins and polynucleotides encoding them |
12/29/1999 | EP0966523A1 Method for the production of selected lymphocytes |
12/29/1999 | EP0966485A1 MUTATED NONACTIVATING IgG2 DOMAINS AND ANTI-CD3 ANTIBODIES INCORPORATING THE SAME |
12/29/1999 | EP0966484A1 Neurotactin and uses therefor |
12/29/1999 | EP0966483A1 Beta-endorphin peptides for treating muscle-wasting diseases |
12/29/1999 | EP0966481A2 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
12/29/1999 | EP0966479A1 Polyprolyl inhibitors of cyclophilin |
12/29/1999 | EP0966478A1 Novel hedgehog-derived polypeptides |
12/29/1999 | EP0966303A2 Polypeptide conjugates for transporting substances across cell membranes |
12/29/1999 | EP0966302A1 Methods of therapeutic administration of anti-cd40l compounds |
12/29/1999 | EP0966300A1 Treatment of autoimmune diseases, including aids |
12/29/1999 | EP0966299A2 Novel pharmaceutical compositions |
12/29/1999 | EP0966298A1 Pharmaceutical compositions for the treatment of the eye |
12/29/1999 | EP0966297A1 Methods for regulating gastrointestinal motility |
12/29/1999 | EP0966296A1 Conjugated peptides, immunological reagent containing same and use thereof for treatment of immunological disorders |
12/29/1999 | EP0966293A1 Medicine for promoting cicatrization and containing thrombocytes |
12/29/1999 | EP0966292A1 Mononuclear phagocytes and their use to promote axonal regeneration |
12/29/1999 | EP0966282A1 Use of angiotensin ii antagonists to treat symptomatic heart failure |
12/29/1999 | EP0966280A1 Ascorbic acid as an adjuvant in the treatment of malignant tumors using chemo- and radiotherapy |
12/29/1999 | EP0966274A2 Treatment of arrhythmias via inhibition of a multifunctional calcium/calmodulin-dependent protein kinase |
12/29/1999 | EP0966271A1 Stabilized, dry pharmaceutical compositions for drug delivery and methods of preparing same |
12/29/1999 | EP0966227A1 Composition containing a radioactive component for treatment of vessel wall |
12/29/1999 | EP0966197A1 Plasmin-depletion therapy |
12/29/1999 | EP0851922B1 Cyclin depenpent kinase binding compounds |
12/29/1999 | EP0774005B1 Surface expression of enzyme in gene directed prodrug therapy |
12/29/1999 | EP0751788B1 Composition including a recombinant plasmid, and uses thereof as a vaccine and drug |
12/29/1999 | EP0668781B1 Lymphokine gene therapy of cancer in combination with tumor antigens |
12/29/1999 | EP0625048B1 Synthesis of human procollagens and collagens in recombinant dna systems |
12/29/1999 | EP0614372B1 Antiviral factor from cd8+ cells |